TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) is now available.
Jubilant Pharmova Limited announced the successful completion of a USFDA pharmacovigilance inspection at its subsidiary, Jubilant Cadista Pharmaceuticals Inc., with no observations. This outcome underscores the company’s commitment to high standards of quality, safety, and compliance, reinforcing its strong position in the pharmaceutical industry.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited is a global company engaged in various pharmaceutical sectors including Radiopharma, Allergy Immunotherapy, and Contract Research Development and Manufacturing Organisation (CRDMO). It operates through its subsidiary Jubilant Pharma Limited, which is involved in manufacturing and supplying radiopharmaceuticals, allergy immunotherapy products, and sterile injectables. The company has a significant presence in regulated markets such as the USA and Europe, and is recognized as a ‘Partner of Choice’ by leading pharmaceutical companies worldwide.
Average Trading Volume: 11,619
Technical Sentiment Signal: Buy
Current Market Cap: 175.8B INR
See more data about JUBLPHARMA stock on TipRanks’ Stock Analysis page.